University of Texas Southwestern Medical Center Department of Pediatrics and Internal Medicine, Division of Allergy and Immunology, 5323 Harry Hines Boulevard F04.206, Dallas, TX, 75390-9063, USA.
Curr Allergy Asthma Rep. 2024 Oct;24(10):581-590. doi: 10.1007/s11882-024-01171-9. Epub 2024 Aug 14.
Cephalosporins are one of the most prescribed antibiotics worldwide and are implicated in a wide range of hypersensitivity reactions (HSR). This review summarizes recent updates in cephalosporin hypersensitivity with a focus on diagnostic testing.
Reported testing strategies to evaluate different immediate and delayed cephalosporin HSR have included skin testing, in vitro testing, and diagnostic drug challenges. However, the diagnostic performance of in vivo and in vitro tests remains unclear across different hypersensitivity endotypes; adequately powered studies investigating the true positive and negative predictive value of these diagnostic modalities are needed using the reference standard of drug challenges to define cephalosporin hypersensitivity. Refinement of diagnostic testing should be guided by growth in our understanding of cephalosporin antigenic determinants. This growth will be crucial in driving further clarification of cross-reactivity between cephalosporins, and potentially delineating streamlined evaluation processes resulting in reduced unnecessary antibiotic avoidance.
头孢菌素类抗生素是全球应用最广泛的抗生素之一,可引发多种类型的过敏反应(HSR)。本综述重点介绍头孢菌素类过敏反应的最新研究进展,包括诊断检测方法。
目前已有多种策略用于评估不同即刻和迟发性头孢菌素 HSR,包括皮肤试验、体外试验和诊断性药物激发试验。然而,不同过敏表型的体内和体外检测的诊断性能尚不清楚;需要采用药物激发试验作为参考标准进行具有足够效能的研究,以明确这些诊断方法的真阳性和真阴性预测值。基于对头孢菌素类抗原决定簇认识的不断深入,应进一步规范诊断检测。这对于阐明头孢菌素类之间的交叉反应,以及潜在的简化评估流程,减少不必要的抗生素回避具有至关重要的作用。